Source: Annual Congress 2009 - Severe asthma and its treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Heider, M. Foerster, A. Moeser, J. Happe, R. Walther, B. Bartuschka, A. Reissig, C. Kroegel (Jena, Germany). Interferon-α (IFN-α)-treatment of uncontrolled severe persistent asthma. Results from a 12-month open label study. Eur Respir J 2009; 34: Suppl. 53, 1877

Member's Comments

No comment yet.

Related content which might interest you: Long-term results of anti-IgE-therapy in severe uncontrolled child asthma. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials Source: International Congress 2017 – Asthma management Year: 2017 Prevalence of severe asthma – results from a population-based study. Source: International Congress 2019 – Asthma and the world Year: 2019 ‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study Source: Annual Congress 2011 - Asthma management and response Year: 2011 Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Effectiveness of early intervention with budesonide in mild persistent asthma — 5-year data from the START study Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma - A long-term prospective cohort study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021 Latent class analyses used to study phenotypes in severe COPD with exacerbation. A pilot study Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010 Buteyko technique (BT) as an adjunct in pulmonary rehabilitation (PR) in patients with asthma and dysfunctional breathing – First results of an ongoing prospective controlled study Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012 Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study Source: Eur Respir J 2007; 30: Suppl. 51, 147s Year: 2007 Characteristics of severe asthma in China with one year follow-up: the C-BIOPRED study Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019 Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Chronic cough associated with COPD exacerbation, pneumonia and death: A prospective study of the general population Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Late-breaking abstract: The forgotten majority: A decrease in persistent but not in intermittent asthma in a large cohort study Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013